(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Age-related Macular Degeneration" report has been added to ResearchAndMarkets.com's offering.
This report assesses key digital marketing metrics of pharma assets in AMD including branded websites for patients and HCPs and unbranded sites. Metrics include website traffic volume, engagement, and source, DDA and paid SEO. Countries include the US and EUCAN.
Genentech's achieved the highest total traffic across branded age-related macular degeneration (AMD) patient sites in the US, with over two million visits from June 2023 to May 2024. This was followed by Bayer's Eylea.us (353,000 visits). Overall, the highest proportion of traffic to branded AMD websites originated from direct sources, followed by organic.
There was minimal paid search engine optimization (SEO) detected across most branded sites in the US. was supported by the most paid SEO at over 1,726 keywords, followed by at 1,130 keywords. Genentech spent the most on Digital Display Advertising (DDA) for at $640,000.
Genentech's achieved the highest total traffic across branded AMD healthcare professional (HCP) sites in the US, with over 390K visits from June 2023 to May 2024. Overall, the highest proportion of traffic to branded AMD websites for HCPs originated from direct sources, followed by paid and organic traffic. was supported by the most paid SEO at 1,082 keywords. Coherus BioSciences spent the most on DDA for at over $51,000.
In the US, few AMD-specific unbranded sites were detected from pharma companies. Between June 2023 - May 2024, Bausch & Lomb's had the highest traffic across that period with over 140,000 visits, followed by Apellis' with over 62,000 visits. DDA spending was only detected across and with over $19,000 and over $2,000, respectively.
No traffic was detected in the five major European markets (5EU: France, Germany, Italy, Spain, UK and Canada) (EUCAN) AMD branded and unbranded websites.
Reasons to Buy
Understand the digital marketing competitive landscape in AMD, with a view of leading patient and HCP branded assets across different regions. See what tactics pharma companies are using to drive traffic to their AMD branded assets for patient and HCPs, such as DDA and paid SEO. Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches. Compare top branded and unbranded assets for patients by how they address and support different patient needs.
Key Topics Covered:
Executive Summary US Branded Websites for Patients US Branded Websites for Physicians EUCAN Branded Websites EUCAN Unbranded Websites Appendix
Companies Featured
Genentech Coherus BioSciences Apellis Bayer Bausch & Lomb
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
MENAFN06092024004107003653ID1108644197
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.